Systems Oncology highlighted as a top AI company in drug discovery and advanced R&D by Deep Knowledge Analytics
Scottsdale, AZ – July 18, 2019 – Systems Oncology is highlighted as one of the top companies worldwide in the most recent “AI for Drug Discovery and Advanced R&D Q2 2019” report by Deep Knowledge Analytics.
This comprehensive report covers new trends and industry developments, as well as key players who are shaping the industry of AI in drug discovery. The report is available online.
About Systems Oncology
Systems Oncology (SO) combines multi-scalar systems modeling with machine learning and big-data to uncover breakthrough insights into cancer biology and expose new therapeutic vulnerabilities. These discoveries are then used to better develop truly novel therapeutic agents. SO has the experience and knowhow needed to intelligently translate scientific insights into smarter clinical development strategies and faster registration paths. It then partners with leading pharmaceutical companies to accelerate the development of breakthrough cancer treatments. Fundamental to the SO approach is a next-generation AI platform for translating scientific insights into innovative cancer therapies with unprecedented speed, scale, and precision.